A randomised phase II trial of the antiemetic effects of Nozinan® compared to a standard dexamethasone containing protocol

Not Applicable

Completed

• Conditions: Vomiting, delayed chemotherapy-induced emesis (DCIE); Signs and Symptoms; Nausea and vomiting

• Registration Number: ISRCTN96357650
• Lead Sponsor: Department of Health (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2003-09-12
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 186

Inclusion Criteria

196 Patients, 93 in each arm.

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in emesis.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration